Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 4 de 4
1.
bioRxiv ; 2023 Sep 24.
Article En | MEDLINE | ID: mdl-38014129

Idiopathic pulmonary fibrosis (IPF) is an aggressive and thus far incurable disease, characterized by aberrant fibroblast-mediated extracellular matrix deposition. Our understanding of the disease etiology is incomplete; however, there is consensus that a reduction-oxidation (redox) imbalance plays a role. In this study we use the autofluorescent properties of two redox molecules, NAD(P)H and FAD, to quantify changes in their relative abundance in living lung tissue of mice with experimental lung fibrosis, and in freshly isolated cells from mouse lungs and humans with IPF. Our results identify cell population-specific intracellular redox changes in the lungs in experimental and human fibrosis. We focus particularly on redox changes within collagen producing cells, where we identified a bimodal distribution of NAD(P)H concentrations, establishing NAD(P)H high and NAD(P)H low sub-populations. NAD(P)H high fibroblasts exhibited elevated pro-fibrotic gene expression and decreased collagenolytic protease activity relative to NAD(P)H low fibroblasts. The NAD(P)H high population was present in healthy lungs but expanded with time after bleomycin injury suggesting a potential role in fibrosis progression. We identified a similar increased abundance of NAD(P)H high cells in freshly dissociated lungs of subjects with IPF relative to controls, and similar reductions in collagenolytic activity in this cell population. These data highlight the complexity of redox state changes in experimental and human pulmonary fibrosis and the need for selective approaches to restore redox imbalances in the fibrotic lung.

2.
J Immunol ; 211(7): 1073-1081, 2023 10 01.
Article En | MEDLINE | ID: mdl-37566492

Idiopathic pulmonary fibrosis (IPF) is a fibrotic age-related chronic lung disease characterized by the accumulation of senescent cells. Whether impaired immune response is responsible for the accumulation of senescent cells in the IPF lung remains unknown. In this study, we characterized the NK phenotype in IPF lungs via flow cytometry using 5-dodecanoylaminofluorescein di-ß-d-galactopyranoside, markers of tissue residence, and chemokine receptors. The effect of the lung microenvironment was evaluated using lung fibroblast (LF) conditioned media (CM), and the bleomycin-induced pulmonary fibrosis mouse model was used to assess the in vivo relationship between NK cells and the accumulation of senescent cells. We found that NK cells from the lower lobe of IPF patients exhibited immune-senescent and impaired CD57-NKG2A+ phenotype. We also observed that culture of NK cells from healthy donors in CM from IPF lower lobe lung fibroblasts induced a senescent-like phenotype and impaired cytotoxic capacity. There is an impaired NK recruitment by LF, and NKs presented decreased migration toward their CM. In addition, NK cell-depleted mice treated with bleomycin showed increased collagen deposition and accumulation of different populations of senescent cells compared with controls. The IPF lung microenvironment induces a dysfunctional NK phenotype limiting the clearance of lung senescent cells and the resolution of lung fibrosis. We propose that impaired NK activity could be one of the mechanisms responsible for perpetuating the accumulation of senescent cells in IPF lungs.


Antineoplastic Agents , Idiopathic Pulmonary Fibrosis , Mice , Animals , Lung/pathology , Idiopathic Pulmonary Fibrosis/chemically induced , Bleomycin/adverse effects , Fibrosis , Antineoplastic Agents/pharmacology , Fibroblasts
3.
Front Immunol ; 12: 735576, 2021.
Article En | MEDLINE | ID: mdl-34899695

Interferon lambda (IFNλ) signaling is a promising therapeutic target against viral infection in murine models, yet little is known about its molecular regulation and its cognate receptor, interferon lambda receptor 1 (IFNLR1) in human lung. We hypothesized that the IFNλ signaling axis was active in human lung macrophages. In human alveolar macrophages (HAMs), we observed increased IFNLR1 expression and robust increase in interferon-stimulated gene (ISG) expression in response to IFNλ ligand. While human monocytes express minimal IFNLR1, differentiation of monocytes into macrophages with macrophage colony-stimulating factor (M-CSF) or granulocyte-macrophage colony-stimulating factor (GM-CSF) increased IFNLR1 mRNA, IFNLR1 protein expression, and cellular response to IFNλ ligation. Conversely, in mice, M-CSF or GM-CSF stimulated macrophages failed to produce ISGs in response to related ligands, IFNL2 or IFNL3, suggesting that IFNLR1 signaling in macrophages is species-specific. We next hypothesized that IFNλ signaling was critical in influenza antiviral responses. In primary human airway epithelial cells and precision-cut human lung slices, influenza infection substantially increased IFNλ levels. Pretreatment of both HAMs and differentiated human monocytes with IFNL1 significantly inhibited influenza infection. IFNLR1 knockout in the myeloid cell line, THP-1, exhibited reduced interferon responses to either direct or indirect exposure to influenza infection suggesting the indispensability of IFNLR1 for antiviral responses. These data demonstrate the presence of IFNλ - IFNLR1 signaling axis in human lung macrophages and a critical role of IFNλ signaling in combating influenza infection.


Influenza, Human/immunology , Interferons/immunology , Macrophages, Alveolar/immunology , Animals , Cells, Cultured , Humans , Macrophages, Alveolar/virology , Mice , Receptors, Interferon/immunology , Signal Transduction/immunology , Interferon Lambda
4.
J Appl Clin Med Phys ; 3(4): 293-301, 2002.
Article En | MEDLINE | ID: mdl-12383049

A comparison of the monitor unit calculations of a commercial 3D computerized treatment planning system (TPS) with "hand" calculations from lookup tables was made for a large number of clinical cases (greater than 13 500 treatment fields). Differences were analyzed by treatment site for prostate, rectum, cranium, and breast. The 3D TPS monitor unit calculation was systematically higher than the "hand" calculation by an amount that depended on the complexity of the treatment geometry. For simple geometries the mean difference was 1% and was as high as 3% for more complicated geometries. The higher value was attributed to an accumulation of differences introduced by multiple factors in the monitor unit calculation. Careful attention to factors such as patient contour could reduce the mean difference. "Hand" calculations were shown to be an accurate and useful tool for verification of TPS monitor unit calculations.


Imaging, Three-Dimensional/methods , Radiation Monitoring/methods , Radiotherapy Planning, Computer-Assisted/methods , Algorithms , Brain/radiation effects , Breast/radiation effects , Cobalt Radioisotopes/therapeutic use , Female , Humans , Male , Prostate/radiation effects , Radiation Monitoring/instrumentation , Radiotherapy Dosage , Radiotherapy Planning, Computer-Assisted/instrumentation , Rectum/radiation effects
...